Status:
COMPLETED
Risk Factors of Neonatal Thrombosis
Lead Sponsor:
Kırıkkale University
Conditions:
Thrombosis
Eligibility:
All Genders
1+ years
Brief Summary
The incidence of symptomatic thrombosis is between 2.4 and 6.8 per 1000 neonatal intensive care unit admission while it is 5.1 per 100 000 live births. Compared to adults, the anticoagulant and fibrin...
Detailed Description
All newborn patients diagnosed with neonatal thrombosis in our NICU between 2014 and 2019; were included in the study. Patients' data: maternal and neonatal characteristics, consanguinity, need for r...
Eligibility Criteria
Inclusion
- All newborn accepted at NICU
Exclusion
- No
Key Trial Info
Start Date :
January 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 10 2022
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT05367466
Start Date
January 1 2014
End Date
April 10 2022
Last Update
May 10 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.